Drug maker Patheon's stock up sharply on 5-year Merck supply deal

TORONTO (CP) - Canadian drug maker Patheon Inc. (TSX:PTI) saw its shares climb almost 22 per cent Friday, after announcing a five-year deal with global drug giant Merck & Co. Inc. Patheon stock rose $1.34 to close at $7.46 on the Toronto Stock Exchange....More